My understanding is that the DOH in the UK are currently developing
guidelines but I don't know when they will be published.
Ian Barlow
Scunthorpe,
UK
> -----Original Message-----
> From: John Whitfield [SMTP:[log in to unmask]]
> Sent: Friday, August 03, 2001 2:53 AM
> To: [log in to unmask]
> Subject: Transmissable spongiform encephalopathies: laboratory
> precautions
>
> How do people handle specimens from patients with suspected TSEs such as
> CJD or vCJD? My feeling is that the universal precautions are the most
> appropriate approach, but there is the problem that the infectious agents
> are probably not sensitive to the usual methods of decontamination. Also,
> if there are official procedures or guidelines we have to comply with them
> even if they don't seem very rational, in this age of legislation and
> litigation.
>
> Maybe our UK contributors have thought this one through and have a
> specific
> policy for avoidance of laboratory-acquired prion diseases?
>
> John Whitfield
> Clinical Biochemistry
> Royal Prince Alfred Hospital
> Sydney, Australia
>
>
> Phone (+61) 2 9515 5246
> Fax (+61) 2 9515 7931
>
> Disclaimer:
> This message is intended for the named addressee and may contain
> confidential information.
> If you are not the intended recipient, please disregard it.
> Views are those of the sender and not necessarily those of Royal Prince
> Alfred Hospital.
|